Aterian (ATER) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Jun, 2026Executive summary
Special Meeting seeks approval for the sale of substantially all assets to Trademark Global for $18 million, subject to adjustments, and related strategic transactions.
Board also seeks approval for an investment transaction with David E. Lazar, involving $7 million in preferred stock, and a shift in strategic direction post-sale.
Proposals include director elections, stock issuances, reverse stock split, authorized share increase, and adjournment authority.
Board unanimously recommends voting FOR all proposals, citing liquidity, market challenges, and strategic alternatives review.
Voting matters and shareholder proposals
Proposals: (1) Asset Sale, (2) Director Elections, (3) Change of Control, (4) Related Party Issuance, (5) Issuance of Common Stock, (6) Reverse Stock Split, (7) Authorized Stock Increase, (8) Adjournment.
Proposals 3, 4, and 5 are interdependent; all must pass to take effect.
Majority approval required for most proposals; director elections by plurality.
Board recommends FOR all proposals.
Board of directors and corporate governance
Board currently consists of five members, with staggered three-year terms.
Two new nominees (Avraham Ben-Tzi and David Natan) recommended by incoming investor Lazar.
If elected, most current directors will step down post-meeting, except for special committee members.
Board committees: Audit and Compensation; majority of directors are independent.
Board has adopted policies on director nominations, stockholder communications, hedging, and compensation recovery.
Latest events from Aterian
- Shareholders will vote on major asset sale, strategic investment, and capital structure changes.ATER
Proxy filing18 Jun 2026 - Special Meeting to vote on asset sale, director elections, and major capital structure changes.ATER
Proxy filing11 Jun 2026 - Vote on asset sale, $7M investment, board overhaul, and major capital changes recommended FOR.ATER
Proxy filing9 Jun 2026 - Asset sale, recapitalization, and board overhaul proposed to address liquidity and strategic challenges.ATER
Proxy filing1 Jun 2026 - Asset sale, major investment, board overhaul, and capital structure changes recommended for approval.ATER
Proxy filing15 May 2026 - Major asset sale and recapitalization planned amid steep losses and going concern risks.ATER
Q1 202615 May 2026 - Asset sale and strategic investment will transfer control to David Lazar, pending shareholder approval.ATER
Proxy filing29 Apr 2026 - Revenue dropped 30% and net loss widened as tariffs and weak demand pressured results.ATER
Q4 202523 Mar 2026 - Q2 guidance raised and new leadership named; profitability targeted for H2 2024.ATER
Investor Update3 Feb 2026